Contract research
It is a long path from the development of an active pharmaceutical ingredient in the lab to an effective drug – a process that takes several years. Campus companies are often involved in this process on behalf of the pharmaceutical and biotech industry or academic groups.
The company Experimental Pharmacology & Oncology Berlin-Buch (EPO) is a leader in preclinical cancer research in Germany. Worldwide, EPO offers customized and comprehensive service for the preclinical development of novel cancer drugs and is specialized in the development of individualized tumor models.
News innovation
DCprime and Glycotope Sign Licensing Agreement to Advance Program Combining Cancer Vaccination and Therapeutic Antibody Platforms
DCprime, the front-runner in the field of relapse vaccines, and Glycotope GmbH, a clinical-stage oncology/immuno-oncology company built on world-leading glycobiology expertise, today announced an expa...
more ...Eckert & Ziegler Records Solid Half-Year Results
Growth Trend for Radiopharmaceuticals Remains Intact
more ...T-knife Completes € 66 Million Series A Financing to Develop Next-Generation T-Cell Therapies
T-knife’s proprietary humanized mouse platform (HuTCR) T-cell receptors expected to provide superior affinity/specificity properties
more ...Events Campus
28.10.2020, 09:00
DIGITALE LIFE SCIENCES – Workshops zu den Grundlagen der Bioinformatik und zum Labor 4.0
Neuer Kurs für Technische Angestellten und Laboranten in den Life Sciences: Überblick über aktuelle Themen zur Bioinformatik, Digitalisierung und Automatisierung
more ...06.11.2020, 09:00
WEITERBILDUNGSTAG LABOR 4.0 FÜR TECHNISCHE ANGESTELLTE UND LABORANT*INNEN
09.11.2020, 09:00
Fachkraft für Molekularbiologie (TÜV)
Das 11-tägige Seminar vermittelt Grundlagen der wichtigsten Labormethoden der modernen Molekularbiologie und Einblicke in die klinische Forschung
more ...
